The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat (Q41145038)

27 September 2017

The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat (English)

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

21 October 2022

main subject

hepatic encephalopathy

1 reference

van den Buijs CA

2

1 reference

27 September 2017

de Haan JG

3

1 reference

27 September 2017

D. K. Bosman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1650320

21 October 2022

C. A. van den Buijs

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1650320

21 October 2022

J. G. de Haan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1650320

21 October 2022

M. A. Maas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1650320

21 October 2022

R. A. Chamuleau

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1650320

21 October 2022

language of work or name

English

0 references

publication date

1 September 1991

1 reference

full work available at URL

27 September 2017

https://api.elsevier.com/content/article/PII:001650859190538V?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

https://api.elsevier.com/content/article/PII:001650859190538V?httpAccept=text/plain

21 October 2022

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

21 October 2022

1 reference

27 September 2017

101

1 reference

27 September 2017

772-781

1 reference

27 September 2017

3

1 reference

The mechanism of hepatic coma

27 September 2017

2

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

GABA receptor multiplicity. Visualization of different receptor types in the mammalian CNS.

21 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Benzodiazepine-GABA receptor-ionophore complex. Current concepts

21 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Hepatic encephalopathy and the gamma-aminobutyric-acid neurotransmitter system.

21 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Metabolism of the inhibitory neurotransmitter gamma-aminobutyric acid in a rabbit model of fulminant hepatic failure

21 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Hepatic encephalopathy: lack of changes of gamma-aminobutyric acid content in plasma and cerebrospinal fluid.

21 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Blood-brain barrier permeability in galactosamine-induced hepatic encephalopathy. No evidence for increased GABA-transport.

21 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Overestimation of serum concentrations of gamma-aminobutyric acid in patients with hepatic encephalopathy by the gamma-aminobutyric acid-radioreceptor assay

21 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Experimental Hepatic Encephalopathy: Changes in the Binding of γ-Aminobutyric Acid

21 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?

21 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathy

21 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

"Endogenous" benzodiazepine activity in body fluids of patients with hepatic encephalopathy

21 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure

21 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands

21 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Supersensitivity of Benzodiazepine Receptors in Hepatic Encephalopathy Due to Fulminant Hepatic Failure in the Rat: Reversal by a Benzodiazepine Antagonist

21 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Selective antagonists of benzodiazepines

21 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Improvement of hepatic encephalopathy treated with flumazenil

21 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.

21 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Hepatic coma: studies on the target organ.

21 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Ro 15-4513: partial inverse agonism at the BZR and interaction with ethanol.

21 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Correlation between electroencephalographic and biochemical indices in acute hepatic encephalopathy in rats

21 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

A computerised EEG-analyzing system for small laboratory animals

21 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Metabolic activity of microcarrier attached liver cells after intraperitoneal transplantation during severe liver insufficiency in the rat

21 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Pharmacokinetic studies on Ro 15-1788, a benzodiazepine receptor ligand, in the brain of the rat.

21 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Assessment of hepatic encephalopathy with visual evoked potentials compared with conventional methods

21 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Visual evoked potential--a tool in the diagnosis of hepatic encephalopathy?

21 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Hepatic encephalopathy. Application of visual evoked responses to test hypotheses of its pathogenesis in rats

21 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Objective measurement of hepatic encephalopathy in pigs by means of spectral analysis and evoked responses.

21 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Pharmacokinetics of benzodiazepine antagonist Ro 15-1788 in cirrhotic patients with moderate or severe liver dysfunction

21 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

In vivo studies of GABAergic effects in experimental hepatic encephalopathy

21 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural gamma-aminobutyric acid (GABA) binding

21 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Plasma GABA, GABA-like activity and the brain GABA-benzodiazepine receptor complex in rats with chronic hepatic encephalopathy

21 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

Hepatic encephalopathy in cirrhotic and portacaval shunted dogs: lack of changes in brain GABA uptake, brain GABA levels, brain glutamic acid decarboxylase activity and brain postsynaptic GABA receptors

21 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

GABAA receptor complex in an experimental model of hepatic encephalopathy: evidence for elevated levels of an endogenous benzodiazepine receptor ligand

21 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/0016-5085(91)90538-V

21 October 2022

Identifiers

0 references

1 reference